City Insurance PLC. (DSE: CITYGENINS)
Bangladesh
· Delayed Price · Currency is BDT 49.50
+2.40 (5.10%)
At close: Nov 14, 2024
City Insurance PLC. Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Premiums & Annuity Revenue | 599.37 | 516.49 | 567.91 | 483.41 | 328.37 | 312.37 | Upgrade
|
| Total Interest & Dividend Income | 123.29 | 94.09 | 66.77 | 63.58 | 47.28 | 46.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.42 | 4.42 | 13.28 | 14.41 | 41.26 | -2.62 | Upgrade
|
| Other Revenue | 71.62 | 58.94 | 66.87 | 55.15 | 23.41 | 24.5 | Upgrade
|
| Total Revenue | 798.7 | 673.93 | 714.83 | 616.54 | 440.32 | 380.55 | Upgrade
|
| Revenue Growth (YoY) | 27.24% | -5.72% | 15.94% | 40.02% | 15.71% | 1.72% | Upgrade
|
| Policy Benefits | 62.92 | 19.54 | 91.08 | 179.64 | 48.52 | 77.2 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 157.5 | 121.19 | 161.72 | 55.37 | 63.26 | 53.37 | Upgrade
|
| Depreciation & Amortization | 7.89 | 7.89 | 6.61 | 7.19 | 5.61 | 5.62 | Upgrade
|
| Selling, General & Administrative | 251.3 | 222.2 | 241.33 | 208.62 | 158.08 | 136.05 | Upgrade
|
| Total Operating Expenses | 479.61 | 370.81 | 500.74 | 450.81 | 275.47 | 272.24 | Upgrade
|
| Operating Income | 319.09 | 303.12 | 214.09 | 165.73 | 164.85 | 108.31 | Upgrade
|
| Interest Expense | - | - | - | -1.22 | -0.43 | -0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.69 | -1.69 | -1.39 | -0.87 | -1.41 | -0.75 | Upgrade
|
| EBT Excluding Unusual Items | 317.4 | 301.44 | 212.7 | 163.63 | 163.01 | 107.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.91 | - | 0.05 | 0.9 | Upgrade
|
| Asset Writedown | -1 | -1 | -1 | -1.02 | -1 | -1 | Upgrade
|
| Pretax Income | 316.39 | 300.42 | 212.61 | 162.61 | 162.06 | 107.24 | Upgrade
|
| Income Tax Expense | 93.35 | 94.79 | 59.03 | 47.89 | 41.31 | 38.7 | Upgrade
|
| Net Income | 223.04 | 205.64 | 153.58 | 114.72 | 120.75 | 68.55 | Upgrade
|
| Net Income to Common | 223.04 | 205.64 | 153.58 | 114.72 | 120.75 | 68.55 | Upgrade
|
| Net Income Growth | 18.59% | 33.90% | 33.88% | -4.99% | 76.16% | -19.95% | Upgrade
|
| Shares Outstanding (Basic) | 68 | 68 | 68 | 68 | 68 | 68 | Upgrade
|
| Shares Outstanding (Diluted) | 68 | 68 | 68 | 68 | 68 | 68 | Upgrade
|
| Shares Change (YoY) | 0.34% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 3.27 | 3.02 | 2.25 | 1.68 | 1.77 | 1.01 | Upgrade
|
| EPS (Diluted) | 3.27 | 3.02 | 2.25 | 1.68 | 1.77 | 1.01 | Upgrade
|
| EPS Growth | 18.18% | 33.90% | 33.88% | -4.99% | 76.16% | -19.95% | Upgrade
|
| Free Cash Flow | 149.91 | 169.02 | 370.87 | 167.32 | 106.92 | 39.46 | Upgrade
|
| Free Cash Flow Per Share | 2.20 | 2.48 | 5.44 | 2.45 | 1.57 | 0.58 | Upgrade
|
| Dividend Per Share | 1.200 | 1.200 | 1.050 | 1.000 | 1.000 | 0.500 | Upgrade
|
| Dividend Growth | 14.29% | 14.29% | 5.00% | 0% | 100.00% | 0% | Upgrade
|
| Operating Margin | 39.95% | 44.98% | 29.95% | 26.88% | 37.44% | 28.46% | Upgrade
|
| Profit Margin | 27.92% | 30.51% | 21.48% | 18.61% | 27.42% | 18.01% | Upgrade
|
| Free Cash Flow Margin | 18.77% | 25.08% | 51.88% | 27.14% | 24.28% | 10.37% | Upgrade
|
| EBITDA | 327.64 | 310.74 | 220.47 | 172.63 | 170.45 | 113.93 | Upgrade
|
| EBITDA Margin | 41.02% | 46.11% | 30.84% | 28.00% | 38.71% | 29.94% | Upgrade
|
| D&A For EBITDA | 8.55 | 7.62 | 6.38 | 6.9 | 5.61 | 5.62 | Upgrade
|
| EBIT | 319.09 | 303.12 | 214.09 | 165.73 | 164.85 | 108.31 | Upgrade
|
| EBIT Margin | 39.95% | 44.98% | 29.95% | 26.88% | 37.44% | 28.46% | Upgrade
|
| Effective Tax Rate | 29.51% | 31.55% | 27.76% | 29.45% | 25.49% | 36.08% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.